(Prototype team page) |
Tugbainanc (Talk | contribs) |
||
Line 1: | Line 1: | ||
− | {{METU_HS_Ankara}} | + | {{METU_HS_Ankara/Inner_Header}} |
<html> | <html> | ||
+ | <header class="ct-pageHeader ct-pageHeader--type2 ct-u-shadowBottom--type2 ct-pageHeader--motive ct-pageHeader--hasDescription ct-u-paddingBoth10"> | ||
+ | <div class="container ct-u-triangleBottomLeft"> | ||
+ | <div class="row"> | ||
+ | <div class="col-md-12"> | ||
+ | <h1 class="text-capitalize ct-fw-600 ct-u-colorWhite"> | ||
+ | Basic Parts | ||
+ | </h1> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </header> | ||
+ | <section class="ct-u-paddingBoth50"> | ||
+ | <div class="container"> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/7/72/T--METU_HS_Ankara--partsbanner.jpg" /> | ||
+ | <table class="table" style="font-size: 17px"> | ||
+ | <thead> | ||
+ | <tr> | ||
+ | <th>Name</th> | ||
+ | <th>Type</th> | ||
+ | <th>Description</th> | ||
+ | <th>Designer</th> | ||
+ | <th>Length</th> | ||
+ | </tr> | ||
+ | </thead> | ||
+ | <tbody> | ||
+ | <tr class="danger"> | ||
+ | <td><a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571000">BBa_K2571000</a></td> | ||
+ | <td><img width="80" src="https://static.igem.org/mediawiki/2018/b/b5/T--METU_HS_Ankara--cparts01.jpg" /></td> | ||
+ | <td>FucO /L-1,2-propanediol oxidoreductase</td> | ||
+ | <td>Tugba Inanc & Ceyhun Kayihan</td> | ||
+ | <td>1152bp</td> | ||
+ | </tr> | ||
+ | <tr class="warning" style="font-size: 17px"> | ||
+ | <td><a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571001">BBa_K2571001</a></td> | ||
+ | <td><img width="80" src="https://static.igem.org/mediawiki/2018/b/b5/T--METU_HS_Ankara--cparts01.jpg" /></td> | ||
+ | <td>Bifunctional gamma-glutamate-cysteine ligase/Glutathione synthetase</td> | ||
+ | <td>Tugba Inanc & Ceyhun Kayihan</td> | ||
+ | <td>2268bp</td> | ||
+ | </tr> | ||
+ | </tbody> | ||
+ | </table> | ||
− | + | <h3>FucO <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571000">(BBa_K2571000)</a></h3> | |
− | <h3> | + | |
− | + | <p> | |
− | <p> | + | FucO is a protein-coding region that codes for L-1,2-propanediol oxidoreductase which is an NADH-linked, homodimer enzyme |
− | + | having the role of acting on furfural. Furfural is a highly toxic substance which inhibits is a toxic inhibitor of microbial | |
+ | fermentations causing cell wall and membrane damages, DNA breakdowns, DNA cleavages and reduced enzymatic activities | ||
+ | (Zheng, 2013; Liu, Ma & Song, 2009). | ||
+ | </p> | ||
+ | <p> | ||
+ | In the presence of furfural, NADPH-dependent oxidoreductases goes active in order to reduce furfural into its less toxic alcohol | ||
+ | derivative - furfuryl alcohol (Zheng, 2013; Wang et al., 2013; Allen et al., 2010). In this pathway, the expression of oxidoreductases | ||
+ | that are NADPH-dependent, such as YqhD, are shown to inhibit the growth and fermentation in E. coli by competing with biosynthesis for | ||
+ | NADPH (Zheng, 2013). | ||
+ | </p> | ||
− | < | + | <p> |
+ | Because the native conversion of NADH to NADPH in E. coli is insufficient to revitalize the NADPH pool during fermentation, the actions | ||
+ | shouldn’t be interfering with NADPH metabolism (Wang et al, 2011). Thus, the overexpression of plasmid-based NADH-dependent propanediol | ||
+ | oxidoreductase (FucO) gene reduces furfural to ultimately improve furfural resistance without detrimentally affecting the biosynthesis | ||
+ | of NADPH (Wang et al, 2011). | ||
+ | </p> | ||
+ | <div class="col-md-12 parts-photo-box"> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/c/c5/T--METU_HS_Ankara--bparts01.jpg" /> | ||
+ | <br /> | ||
+ | <i class="parts-info"> | ||
+ | Figure 1: <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571000">BBa_K2571000</a>: fucO was cloned into pSB1C3. | ||
+ | </i> | ||
+ | </div> | ||
+ | <div style="clear: both"></div> | ||
+ | <div class="col-md-6"> | ||
+ | <img width="500" src="https://static.igem.org/mediawiki/2018/6/67/T--METU_HS_Ankara--bparts02.jpg" /> | ||
+ | </div> | ||
− | <div class=" | + | <div class="col-md-6"> |
+ | <p> | ||
+ | We’ve inserted the gene our FucO, which is our basic part 1,to pSB1C3 backbone and transformed it to DH5- alpha. After plasmid | ||
+ | isolation, we’ve checked the orientation with FucO left and VR primers and expected to see a band of 625 bp. | ||
+ | </p> | ||
+ | </div> | ||
− | < | + | <div style="clear: both"></div> |
− | + | ||
− | <p> | + | <p> |
− | + | FucO and VR primers are as below:<br> | |
− | < | + | FucO left: GTGATAAGGATGCCGGAGAA<br> |
− | </ | + | VR: ATTACCGCCTTTGAGTGAGC |
+ | </p> | ||
+ | <h3>GSH <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571001">(BBa_K2571001)</a></h3> | ||
− | < | + | <p> |
− | + | GSH as is a protein-coding region that codes for Bifunctional gamma glutamate cysteine ligase/ Glutathione synthetase. | |
− | + | </p> | |
− | + | ||
− | + | ||
− | + | ||
− | <div class=" | + | <p> |
− | < | + | Glutathione (GSH) is known to be an important antioxidant that is a sulfur compound; a tripeptide composed of three amino acids |
− | <p> | + | (cysteine, glycine and glutamic acid) and a non-protein thiol (Pizzorno, 2014; Lu, 2013). GHS is, furthermore, found in thiol-reduced |
− | </div> | + | form which accounts for its strength as an antioxidant. |
+ | |||
+ | </p> | ||
+ | |||
+ | <p> | ||
+ | Reactive oxygen species (ROS) are harmful substances that distort protein based matters by taking electrons and also causes oxidative | ||
+ | stress (Lu, 2013) which occur during the fermentation process and is another major setback. The chemical structure of the protein-based | ||
+ | substances such as the DNA are altered and become therefore become dysfunctional because of ROS (Lu, 2013; Burton & Jauniaux, 2011). | ||
+ | </p> | ||
+ | |||
+ | <p> | ||
+ | GSH is generally found in the thiol-reduced form which is crucial for detoxification of ROS and free radicals. which cause oxidative | ||
+ | stress. (Lu, 2013; Burton & Jauniaux, 2011). | ||
+ | </p> | ||
+ | |||
+ | <p> | ||
+ | Antioxidants like GSH play an important role in the detoxification of ROS and reactive oxygen species by directly acting as electron | ||
+ | donors;, changing the unbalanced electron state of the free radicals and turningand, turning them into less harmful substances or affect | ||
+ | them indirectly by getting in the way of the expression of free radical generating enzymes (Lü et al., 2014). | ||
+ | </p> | ||
+ | |||
+ | <div class="col-md-12 parts-photo-box"> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/6/62/T--METU_HS_Ankara--bparts03.jpg" /> | ||
+ | <br> | ||
+ | <i class="parts-info" style="margin-bottom: 20px"> | ||
+ | Figure 3:<a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571001">BBa_K2571001</a>: GSH was cloned into pSB1C3. | ||
+ | </i> | ||
+ | </div> | ||
+ | |||
+ | <div style="clear: both"></div> | ||
+ | |||
+ | <div class="col-md-6" style="margin-bottom: 30px"> | ||
+ | <img width="500" src="https://static.igem.org/mediawiki/2018/6/6e/T--METU_HS_Ankara--bparts04.jpg" /> | ||
+ | <br> | ||
+ | <i class="parts-info"> | ||
+ | Figure 4: BBa_K2571001 check with GSH specific primers. Expected band length: 225 bp. GSH basic well show positive results. | ||
+ | </i> | ||
+ | </div> | ||
+ | |||
+ | <div class="col-md-6"> | ||
+ | <p> | ||
+ | We’ve inserted the geneour GSH, basic part 2, to pSB1C3 backbone and transformed it to DH5 alpha. After plasmid isolation, | ||
+ | we’ve checked the orientation with GSH specific primers and expected to see a band of 225 bp. | ||
+ | </p> | ||
+ | </div> | ||
+ | |||
+ | <div style="clear: both"></div> | ||
+ | |||
+ | <p> | ||
+ | GSH left and right primers are shown as below: | ||
+ | <br> | ||
+ | GSH left: TCGGAGGCTAAAACTCAGGA | ||
+ | <br> | ||
+ | GSH right: GTGGGCAGTCCAGTCGTAAT | ||
+ | </p> | ||
+ | |||
+ | |||
+ | <section class="ct-u-paddingTop50 ct-u-paddingBottom80 ct-u-borderBoth ct-u-backgroundGray"> | ||
+ | <div class="container"> | ||
+ | <div class="row"> | ||
+ | <div class="col-md-12"> | ||
+ | <div class="panel-group" id="accordion"> | ||
+ | <div class="panel panel-default"> | ||
+ | <div class="panel-heading"> | ||
+ | <h4 class="panel-title"> | ||
+ | <a data-toggle="collapse" data-parent="#accordion" href="#collapseOne"> | ||
+ | References | ||
+ | </a> | ||
+ | </h4> | ||
+ | </div> | ||
+ | <div id="collapseOne" class="panel-collapse collapse"> | ||
+ | <ul> | ||
+ | <li> | ||
+ | <span style="font-weight:bold">Allen, S. A., Clark, W., McCaffery, J. M., Cai, Z., Lanctot, A., Slininger, P. J., … Gorsich, | ||
+ | S. W.</span> (2010). Furfural induces reactive oxygen species accumulation and cellular damage in | ||
+ | Saccharomyces cerevisiae. Biotechnology for Biofuels, 3, 2. | ||
+ | <a href="http://doi.org/10.1186/1754-6834-3-2">http://doi.org/10.1186/1754-6834-3-2</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <span style="font-weight:bold">Chou, H.-H., Marx, C. J., & Sauer, U.</span> (2015). Transhydrogenase Promotes the Robustness and Evolvability of | ||
+ | E. coli Deficient in NADPH Production. PLoS Genetics, 11(2), e1005007. | ||
+ | <a href="http://doi.org/10.1371/journal.pgen.1005007">http://doi.org/10.1371/journal.pgen.1005007</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <span style="font-weight:bold">Liu, Z.L., Ma M., Song, M.</span>(2009). Evolutionarily engineered ethanologenic yeast detoxifies lignocellulosic | ||
+ | biomass conversion inhibitors by reprogrammed pathways. Mol Genet Genomics 282, 233-244. doi: | ||
+ | 10.1007/s00438-009-0461-7 | ||
+ | </li> | ||
+ | <li> | ||
+ | <span style="font-weight:bold">Wang, X., Miller, E. N., Yomano, L. P., Zhang, X., Shanmugam, K. T., & Ingram, L. O.</span> (2011). Increased | ||
+ | Furfural Tolerance Due to Overexpression of NADH-Dependent Oxidoreductase FucO in Escherichia coli Strains | ||
+ | Engineered for the Production of Ethanol and Lactate. Applied and Environmental Microbiology, 77(15), | ||
+ | 5132–5140. <a href="http://doi.org/10.1128/AEM.05008-11">http://doi.org/10.1128/AEM.05008-11</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <span style="font-weight:bold">Zheng, H., Wang, X., Yomano, L.P., Geddes, R.D, Shanmugan, K. T., Ingram, L.O.</span> (2013). Improving | ||
+ | Escherichia coli FucO for Furfural Tolerance by Saturation Mutagenesis of Individual Amino Acid Positions. | ||
+ | Applied and Environmental Microbiology Vol 79, no 10. 3202–3208. | ||
+ | <a href="http://aem.asm.org/content/79/10/3202.full.pdf+html">http://aem.asm.org/content/79/10/3202.full.pdf+html</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <span style="font-weight:bold">Lu, S. C.</span> (2013). Glutathione Synthesis. Biochemical et Biophysica Acta, 1830(5), 3143–3153. | ||
+ | <a href="http://doi.org/10.1016/j.bbagen.2012.09.008">http://doi.org/10.1016/j.bbagen.2012.09.008</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <span style="font-weight:bold">National Center for Biotechnology Information.</span> PubChem Compound Database; CID=124886, | ||
+ | <a href="https://pubchem.ncbi.nlm.nih.gov/compound/124886">https://pubchem.ncbi.nlm.nih.gov/compound/124886</a> (accessed July 18, 2018). | ||
+ | <a href="https://pubchem.ncbi.nlm.nih.gov/compound/124886#section=Top">https://pubchem.ncbi.nlm.nih.gov/compound/124886#section=Top</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <span style="font-weight:bold">Pizzorno, J.</span> (2014). Glutathione! Integrative Medicine: A Clinician’s Journal, 13(1), 8–12. | ||
+ | <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684116/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684116/</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <span style="font-weight:bold">Burton, G. J., & Jauniaux, E.</span> (2011). Oxidative stress. Best Practice & Research. Clinical Obstetrics & | ||
+ | Gynaecology, 25(3), 287–299. | ||
+ | <a href="http://doi.org/10.1016/j.bpobgyn.2010.10.016">http://doi.org/10.1016/j.bpobgyn.2010.10.016</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <span style="font-weight:bold">Lü, J.-M., Lin, P. H., Yao, Q., & Chen, C.</span> (2010). Chemical and molecular mechanisms of antioxidants: | ||
+ | experimental approaches and model systems. Journal of Cellular and Molecular Medicine, 14(4), 840–860. | ||
+ | <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684116/">http://doi.org/10.1111/j.1582-4934.2009.00897.x</a> | ||
+ | </li> | ||
+ | </ul> | ||
+ | |||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </section> | ||
+ | |||
+ | </div> | ||
+ | </section> | ||
</html> | </html> | ||
+ | |||
+ | {{METU_HS_Ankara/footer}} |
Revision as of 09:43, 2 October 2018